These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27234216)

  • 21. [Sentinel node and breast cancer: A state-of-the-art in 2019].
    Zeitoun J; Babin G; Lebrun JF
    Gynecol Obstet Fertil Senol; 2019 Jun; 47(6):522-526. PubMed ID: 30959186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients.
    El Hage Chehade H; Headon H; El Tokhy O; Heeney J; Kasem A; Mokbel K
    Am J Surg; 2016 Nov; 212(5):969-981. PubMed ID: 27671032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De-escalating axillary management after neoadjuvant chemotherapy in breast cancer: The ratio of positive sentinel lymph nodes matters.
    Aragón-Sánchez S; Sánchez-Bayona R; López-Marín L; Ciruelos-Gil E; Parrilla-Rubio L; Zaragoza-Ballester P; Galindo-Izquierdo A; García-Chapinal B; Álvaro-Valiente L; Oliver-Pérez MR
    Surg Oncol; 2024 Jun; 54():102062. PubMed ID: 38531288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sentinel node biopsy and neoadjuvant chemotherapy in the treatment of breast cancer.
    Gatek J; Vrana D; Hnatek L; Bakala J; Dudesek B; Duben J; Musil T
    J BUON; 2012; 17(2):265-70. PubMed ID: 22740204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
    Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
    Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of sentinel lymph node biopsy in breast cancer women N1-N2 with complete axillary response after neoadjuvant chemotherapy. Multicentre study in Tarragona.
    Carrera D; de la Flor M; Galera J; Amillano K; Gomez M; Izquierdo V; Aguilar E; López S; Martínez M; Martínez S; Serra JM; Pérez M; Martin L
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):221-5. PubMed ID: 26848141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice.
    El Hage Chehade H; Headon H; Kasem A; Mokbel K
    Anticancer Res; 2016 Apr; 36(4):1461-71. PubMed ID: 27069121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer.
    Marrazzo A; Damiano G; Taormina P; Buscemi S; Lo Monte AI; Marrazzo E
    Clin Breast Cancer; 2017 Apr; 17(2):e53-e57. PubMed ID: 27840075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing of the sentinel lymph node biopsy in breast cancer patients receiving neoadjuvant therapy - recommendations for clinical guidance.
    Fontein DB; van de Water W; Mieog JS; Liefers GJ; van de Velde CJ
    Eur J Surg Oncol; 2013 May; 39(5):417-24. PubMed ID: 23473972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Péley G; Török K; Farkas E; Mátrai Z; Horváth Z; Sinkovics I; Hitre E; Rényi-Vámos F; Orosz Z; Köves I
    Magy Onkol; 2006; 50(1):19-23. PubMed ID: 16617379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility, accuracy and prognosis of sentinel lymph node biopsy before neoadjuvant therapy in breast cancer. A prospective study.
    Garcia-Tejedor A; Falo C; Quetglas C; Soler T; Marqueta B; Ortega R; Gil-Gil M; Pernas S; Fernandez-Montolí E; Pla MJ; Guma A; Bajen M; Benitez A; Eraso A; Campos M; Petit A; Ponce J
    Int J Surg; 2017 Mar; 39():141-147. PubMed ID: 28153783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M
    Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of Novel Sentinel Lymph Node Biopsy Techniques in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Ersoy YE; Kadioglu H
    Clin Breast Cancer; 2018 Aug; 18(4):e555-e559. PubMed ID: 29429940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel Node Lymph Node Surgery After Neoadjuvant Therapy: Principles and Techniques.
    Racz JM; Caudle AS
    Ann Surg Oncol; 2019 Oct; 26(10):3040-3045. PubMed ID: 31342394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy.
    Khan A; Sabel MS; Nees A; Diehl KM; Cimmino VM; Kleer CG; Schott AF; Hayes DF; Chang AE; Newman LA
    Ann Surg Oncol; 2005 Sep; 12(9):697-704. PubMed ID: 16079956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis.
    Park S; Park JM; Cho JH; Park HS; Kim SI; Park BW
    Ann Surg Oncol; 2013 Sep; 20(9):2858-65. PubMed ID: 23645483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.
    Espinosa-Bravo M; Navarro-Cecilia J; Ramos Boyero M; Diaz-Botero S; Dueñas Rodríguez B; Luque López C; Ramos Grande T; Ruano Perez R; Peg V; Rubio IT
    Breast; 2017 Feb; 31():40-45. PubMed ID: 27810698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Feasibility of sentinel lymph node biopsy peri-neoadjuvant chemotherapy in breast cancer].
    Zhao J; Song ZW; Huang Y; Hao XP; Liang F; Wang SB; Jin SJ; Yu CZ
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(36):2538-41. PubMed ID: 23158793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer.
    Papa MZ; Zippel D; Kaufman B; Shimon-Paluch S; Yosepovich A; Oberman B; Sadetzki S
    J Surg Oncol; 2008 Nov; 98(6):403-6. PubMed ID: 18683193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.